Invention Grant
- Patent Title: Use of lanostane and Poria extract in treating diabetes
- Patent Title (中): 使用羊毛甾醇和茯苓萃取物治疗糖尿病
-
Application No.: US12854037Application Date: 2010-08-10
-
Publication No.: US09084798B2Publication Date: 2015-07-21
- Inventor: Hang-Ching Lin , Yu-Chuan Huang , Tsu-Chung Chang , Wen-Liang Chang
- Applicant: Hang-Ching Lin , Yu-Chuan Huang , Tsu-Chung Chang , Wen-Liang Chang
- Applicant Address: CN Zhejiang
- Assignee: Sinphar Tian-Li Pharmaceutical Co., Ltd (Hangzhou)
- Current Assignee: Sinphar Tian-Li Pharmaceutical Co., Ltd (Hangzhou)
- Current Assignee Address: CN Zhejiang
- Agency: Cesari and McKenna, LLP
- Priority: CN200910168119 20090828
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/33 ; A01N45/00 ; A61K31/56 ; A61K31/575 ; A61K36/076
Abstract:
A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.
Public/Granted literature
- US20110053899A1 USE OF LANOSTANE AND PORIA EXTRACT IN TREATING DIABETES Public/Granted day:2011-03-03
Information query
IPC分类:
